Bilder in dieser Kollektion

March 2, 2021, Munich, Bavaria, Germany: Starting with some 10,000 doses of the AstraZeneca Covid-19 vaccine, the Bavarian Police has begun vaccinating its Bereitschaftspolizei and Einsatzeinheiten- specialized police units that deal with demonstrations, riots, and other missions. Germanyâ€⠢s vaccine program has been criticized for being extremely slow, with numerous nations surpassing not only percentage of the population vaccinated, but also absolute numbers as they vaccinate those at risk and simultaneously the general population to achieve herd immunity faster. Without an increase in rate, Germany is expected to require over 90 weeks to vaccinate the country. The federal government has already refused measures to deprioritize As - ZUMAb160 20210302_zbp_b160_062 Copyright: xSachellexBabbarx

March 2, 2021, Munich, Bavaria, Germany: The administration of the AstraZeneca Covid vaccine to Munich Police. Starting with some 10,000 doses of the AstraZeneca Covid-19 vaccine, the Bavarian Police has begun vaccinating its Bereitschaftspolizei and Einsatzeinheiten- specialized police units that deal with demonstrations, riots, and other missions. Germanyâ€⠢s vaccine program has been criticized for being extremely slow, with numerous nations surpassing not only percentage of the population vaccinated, but also absolute numbers as they vaccinate those at risk and simultaneously the general population to achieve herd immunity faster. Without an increase in rate, Germany is expected to require over 90 weeks to vaccinate the country. - ZUMAb160 20210302_zbp_b160_041 Copyright: xSachellexBabbarx

News Bilder des Tages (210217) -- BRUSSELS, Feb. 17, 2021 -- European Commission President Ursula von der Leyen attends a press conference in Brussels, Belgium, on Feb. 17, 2021. The (EU) on Wednesday stepped up its efforts to detect and fight COVID-19 variants by bringing together various stakeholders to develop new and adapted vaccines. A new project called HERA Incubator will gather researchers, biotech companies, manufacturers and public authorities in the EU and globally to detect new coronavirus variants, provide incentives to develop new and adapted vaccines, speed up the approval process for these vaccines, and ensure the scaling up of manufacturing capacities. ( Handout via Xinhua) BELGIUM-BRUSSELS-EU-COVID-19-VARIANTS-HERA INCUBATOR EuropeanxUnion